Man Group’s The Oncology Institute Warrant TOIIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.94K Hold
88,824
﹤0.01% 2367
2025
Q4
$14.2K Hold
88,824
﹤0.01% 2223
2025
Q3
$11.9K Hold
88,824
﹤0.01% 2179
2025
Q2
$4.56K Hold
88,824
﹤0.01% 2145
2025
Q1
$2.13K Hold
88,824
﹤0.01% 2150
2024
Q4
$622 Hold
88,824
﹤0.01% 1963
2024
Q3
$1.78K Hold
88,824
﹤0.01% 1942
2024
Q2
$1.8K Hold
88,824
﹤0.01% 1998
2024
Q1
$20K Hold
88,824
﹤0.01% 2094
2023
Q4
$11.5K Buy
+88,824
New +$14K ﹤0.01% 2023
2023
Q3
Sell
-94,740
Closed -$7.71K 1890
2023
Q2
$4.26K Buy
+94,740
New +$5.21K ﹤0.01% 1938
2023
Q1
Sell
-94,740
Closed -$11.7K 2048
2022
Q4
$10.4K Hold
94,740
﹤0.01% 1981
2022
Q3
$48K Buy
+94,740
New +$66K ﹤0.01% 1898
2022
Q2
Sell
-94,740
Closed -$87.2K 2404
2022
Q1
$109K Hold
94,740
﹤0.01% 2043
2021
Q4
$65K Hold
94,740
﹤0.01% 1898
2021
Q3
$120K Hold
94,740
﹤0.01% 1803
2021
Q2
$164K Hold
94,740
﹤0.01% 1823
2021
Q1
$114K Hold
94,740
﹤0.01% 1793
2020
Q4
$185K Hold
94,740
﹤0.01% 1745
2020
Q3
$161K Buy
+94,740
New +$156K ﹤0.01% 1717

Other funds holding TOIIW

Man Group's TOIIW Position: Q1 2026 in Review

Man Group held its The Oncology Institute Warrant (TOIIW) position steady in Q1 2026 at 88,824 shares worth $4.94K. The position accounts for ﹤0.01% of the portfolio, ranked #2367.

Man Group first reported a position in TOIIW in Q3 2020 and has held it in 20 quarters since. The position peaked at $185K in Q4 2020. 11 funds tracked by Wall St. Rank hold TOIIW as of Q1 2026.

  • Man Group held 88,824 shares of The Oncology Institute Warrant worth $4.94K as of Q1 2026.
  • Man Group left its The Oncology Institute Warrant share count unchanged in Q1 2026.
  • The Oncology Institute Warrant made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #2367 holding.
  • Man Group first reported a position in The Oncology Institute Warrant in Q3 2020 and has held it in 20 quarters since.
  • Man Group's The Oncology Institute Warrant position peaked at $185K in Q4 2020.
  • 11 funds tracked by Wall St. Rank held The Oncology Institute Warrant as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.